YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
Yan Xia(Northwest Women's and Children's Hospital), Heng‐Yu Fan(Zhejiang University)
Cited by 176
Related Papers
YAP/TEAD Co-Activator Regulated Pluripotency and Chemoresistance in Ovarian Cancer Initiated Cells
|PLoS ONE|2014|81
RNF8 mediates histone H3 ubiquitylation and promotes glycolysis and tumorigenesis
|The Journal of Experimental Medicine|2017|41